Lankenau Heart Group physician practices recognized by American Heart Association for commitment to reducing cholesterol
Bryn Mawr, PA — Lankenau Heart Group physician practices, part of Main Line Health’s Lankenau Heart Institute, have been recognized by the American Heart Association (AHA) for their commitment to reducing the risk of heart disease and stroke by managing cholesterol.
Sixteen Lankenau Heart Group practices earned the AHA’s Check. Change. Control. Cholesterol™ Participation award in recognition of the Group’s collective efforts.
More than 94 million adults in the United States have elevated cholesterol and only slightly more than half of them are appropriately managing the condition. High cholesterol is one of the major controllable risk factors for coronary heart disease, heart attack and stroke. If a person has other risk factors, such as smoking, high blood pressure or diabetes, their risk increases even more.
To effectively manage cholesterol among patients, Lankenau Heart Group physicians prescribed statins for adult patients who:
- Had a diagnosis of clinical atherosclerotic cardiovascular disease
- Had been previously diagnosed or had a family history of high cholesterol
- Were between ages 40-75 with Type 1 or Type 2 diabetes and an LDL of 70-189 mg/dL
“Reducing cholesterol – and the risk of heart attack and stroke – is always a primary focus for our Lankenau Heart Group physician practices,” said William Gray, MD, System Chief of Cardiovascular Disease at Main Line Health and Co-Director of Lankenau Heart Institute. “That means following proven, research-based clinical guidelines such as those included in the Check. Change. Control. Cholesterol initiative. At Lankenau Heart Institute, we provide the most advanced surgical and interventional care for complex cardiac issues, but preventing heart disease and stroke is how to avoid surgery in the first place.”
To help people better understand their risk and learn to manage their cholesterol, the American Heart Association launched its Check. Change. Control. Cholesterol initiative in 2017. Participating practices have access to tools and resources that allow clinicians to easily implement guidelines set forth by the American Heart Association to improve cholesterol control.
About Lankenau Heart Institute
Lankenau Heart Institute is Main Line Health's premier comprehensive cardiovascular program, bringing together the collective expertise of cardiologists, cardiovascular surgeons and advanced practice providers across all four of the System's acute care hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital. Through a coordinated approach, Lankenau Heart Institute offers a full continuum of high-quality cardiovascular care, from prevention and diagnostics to advanced treatments and rehabilitation, delivered with a commitment to excellence in outcomes and patient experience.
A leader in innovation, Lankenau Heart Institute is at the forefront of minimally invasive and transcatheter procedures for coronary revascularization, valve repair and replacement, complex aortic surgery and the treatment of advanced heart failure and arrhythmias. Its pioneering work in robotic-assisted and beating-heart techniques and minimally invasive valve repair continue to shape the future of cardiovascular care. With a robust and growing presence in national clinical trials, its physicians regularly participate in groundbreaking research focused on the latest therapies, technologies and procedures, focusing primarily on less invasive approaches.
About Main Line Health
Founded in 1985, Main Line Health® is a not-for-profit health system serving the Philadelphia region and beyond. Main Line Health consists of five hospitals, six health centers and over 150 medical practice locations. The System has more than 14,000 employees and over 2,100 employed and independent physicians and advanced practice providers.
At its core are four of the region's most respected acute care hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital — as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehab Hospital. Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, providing skilled home healthcare, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; and Lankenau Institute for Medical Research, a biomedical research organization.
Main Line Health's medical staff benefits from a collaborative relationship including independent physicians, community healthcare professionals and hospital-based experts from Main Line HealthCare, the employed multi-specialty physician network of Main Line Health.
Main Line Health collaborates with top experts to deliver exceptional specialty care. Through our affiliation with the Children's Hospital of Philadelphia, doctors and advanced practice providers care for pediatric patients at select Main Line Health locations, including the neonatal intensive care units at Main Line Health's four acute care hospitals, as well as Bryn Mawr Hospital's Inpatient Pediatric Unit and Emergency Department. Jefferson Health neurosurgeons and neurointerventionalists provide 24/7 specialized care, including neurointervention and lifesaving stroke care, and trauma surgeons provide critical care to our patients. Through our affiliation with Sheppard Pratt — a nonprofit provider of mental health services, substance use, developmental disability and other comprehensive behavioral health support — patients receive compassionate care in a welcoming environment.
For more information, visit mainlinehealth.org and connect with us on social media:
LinkedIn: www.linkedin.com/company/main-line-health
Facebook: www.facebook.com/mainlinehealth
X (formerly known as Twitter): www.twitter.com/mainlinehealth
Instagram: www.instagram.com/mainlinehealth